130 related articles for article (PubMed ID: 33045486)
1. Prevalence and predictors of weight loss during induction therapy for childhood acute lymphoblastic leukemia.
Hill R; Hamby T; Johnson D; Boren C; Downs H; Ray A
Nutrition; 2021 Jan; 81():110937. PubMed ID: 33045486
[TBL] [Abstract][Full Text] [Related]
2. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children's Oncology Group.
Withycombe JS; Smith LM; Meza JL; Merkle C; Faulkner MS; Ritter L; Seibel NL; Moore K
Pediatr Blood Cancer; 2015 Mar; 62(3):434-9. PubMed ID: 25407299
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia.
Seki Y; Okamoto Y; Kodama Y; Nishikawa T; Tanabe T; Nakagawa S; Mizota M; Kawano Y
J Pediatr Hematol Oncol; 2018 Aug; 40(6):e334-e337. PubMed ID: 29401101
[TBL] [Abstract][Full Text] [Related]
4. Association between obesity at diagnosis and weight change during induction and survival in pediatric acute lymphoblastic leukemia.
Ethier MC; Alexander S; Abla O; Green G; Lam R; Sung L
Leuk Lymphoma; 2012 Sep; 53(9):1677-81. PubMed ID: 22390648
[TBL] [Abstract][Full Text] [Related]
5. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia.
Browne EK; Zhou Y; Chemaitilly W; Panetta JC; Ness KK; Kaste SC; Cheng C; Relling MV; Pui CH; Inaba H
Cancer; 2018 Nov; 124(21):4248-4259. PubMed ID: 30358906
[TBL] [Abstract][Full Text] [Related]
6. The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL).
Dare JM; Moppett JP; Shield JP; Hunt LP; Stevens MC
Pediatr Blood Cancer; 2013 Dec; 60(12):E157-9. PubMed ID: 23868820
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma.
Demedis J; Scarbro S; Suresh K; Maloney K; Forlenza GP
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e154-e160. PubMed ID: 36715999
[TBL] [Abstract][Full Text] [Related]
8. Mucormycosis diagnosed during induction chemotherapy in five pediatric patients with acute lymphoblastic leukemia.
Aftandilian C; Eguiguren L; Mathew R; Messner A
Pediatr Blood Cancer; 2019 Sep; 66(9):e27834. PubMed ID: 31131954
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs.
McCormick MC; Sharp E; Kalpatthi R; Zullo J; Gurtunca N; Zhang J; Krafty R; Raman S
Pediatr Blood Cancer; 2020 Sep; 67(9):e28475. PubMed ID: 32589365
[TBL] [Abstract][Full Text] [Related]
10. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
Lowas SR; Marks D; Malempati S
Pediatr Blood Cancer; 2009 Jul; 52(7):814-8. PubMed ID: 19260096
[TBL] [Abstract][Full Text] [Related]
12. Changes in Nutritional Status during Induction Phase and Their Association with Fever and Minimal Residual Disease in Paediatric Acute Lymphoblastic Leukaemia.
Gustaitė S; Everatt V; Kairienė I; Vaišnorė R; Rascon J; Vaitkevičienė GE
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374212
[No Abstract] [Full Text] [Related]
13. THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.
Greiner J; Schrappe M; Claviez A; Zimmermann M; Niemeyer C; Kolb R; Eberl W; Berthold F; Bergsträsser E; Gnekow A; Lassay E; Vorwerk P; Lauten M; Sauerbrey A; Rischewski J; Beilken A; Henze G; Korte W; Möricke A;
Haematologica; 2019 Apr; 104(4):756-765. PubMed ID: 30262570
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in obese patients undergoing induction therapy for acute leukemia.
Dombrowski L; Mohassel L
J Oncol Pharm Pract; 2019 Jul; 25(5):1058-1065. PubMed ID: 29726788
[TBL] [Abstract][Full Text] [Related]
15. ICU Admission in Children With Acute Lymphoblastic Leukemia in Sweden: Prevalence, Outcome, and Risk Factors.
Ranta S; Broman LM; Abrahamsson J; Berner J; Fläring U; Hed Myrberg I; Kalzén H; Karlsson L; Mellgren K; Nilsson A; Norén-Nyström U; Palle J; von Schewelov K; Svahn JE; Törnudd L; Heyman M; Harila-Saari A
Pediatr Crit Care Med; 2021 Dec; 22(12):1050-1060. PubMed ID: 34074998
[TBL] [Abstract][Full Text] [Related]
16. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Mullins J; Ferry RJ; DeAngulo G; Thomas PJ; Estrada J; Pitney A; Pollock BH
Pediatr Blood Cancer; 2005 Dec; 45(7):960-3. PubMed ID: 15700246
[TBL] [Abstract][Full Text] [Related]
17. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
[TBL] [Abstract][Full Text] [Related]
18. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.
Hakim H; Dallas R; Zhou Y; Pei D; Cheng C; Flynn PM; Pui CH; Jeha S
Cancer; 2016 Mar; 122(5):798-805. PubMed ID: 26700662
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of parent-reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy.
Steur LMH; Grootenhuis MA; Van Someren EJW; Van Eijkelenburg NKA; Van der Sluis IM; Dors N; Van den Bos C; Tissing WJE; Kaspers GJL; Van Litsenburg RRL
Pediatr Blood Cancer; 2020 Apr; 67(4):e28165. PubMed ID: 31944548
[TBL] [Abstract][Full Text] [Related]
20. Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Matsushima S; Kobayashi R; Sano H; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Pediatr Blood Cancer; 2021 Feb; 68(2):e28763. PubMed ID: 33047887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
